IE
REPL icon

Israel Englander’s Replimune Group REPL Stock Holding History

Israel Englander’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Buy
168,500
+61,000
+57% +$373K ﹤0.01% 3872
2026
Q1 		$822K Buy
+107,500
New +$822K ﹤0.01% 4516
2025
Q3 		– Sell
-412,700
Closed -$3.83M – 6395
2025
Q2 		$3.83M Buy
+412,700
New +$3.6M ﹤0.01% 3258

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Israel Englander's REPL Position: Q2 2026 in Review

Israel Englander increased its Replimune Group (REPL) stake by 173% in Q2 2026, buying an estimated $3.19M and bringing the position to 821,958 shares worth $9.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2372.

Israel Englander first reported a position in REPL in Q4 2019 and has held it in 26 quarters since. The position peaked at $28.1M in Q2 2024. 198 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Israel Englander held 821,958 shares of Replimune Group worth $9.1M as of Q2 2026.
  • Israel Englander bought 521,125 Replimune Group shares in Q2 2026, an estimated $3.19M.
  • Replimune Group made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2372 holding.
  • Israel Englander first reported a position in Replimune Group in Q4 2019 and has held it in 26 quarters since.
  • Israel Englander's Replimune Group position peaked at $28.1M in Q2 2024.
  • 198 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.